Home UniQure Deal Confirms Red-Hot Interest In Advanced Therapies
 

Keywords :   


UniQure Deal Confirms Red-Hot Interest In Advanced Therapies

2015-04-08 03:15:03| Trucking - Topix.net

If there is any sign that pharma is beating the bushes to flush out promising advanced therapies, it is that Bristol-Myers For a near-term outlay of nearly $100m, Bristol-Myers gets the heart failure candidate AAV-S100A1 and three other targets. Along with Bluebird Bio , Celladon and Voyager Therapeutics, UniQure shows that gene therapy has begun a modest but noteworthy renaissance.

Tags: advanced interest deal confirms

Category:Transportation and Logistics

Latest from this category

All news

01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
31.10Atlantic Tropical Weather Outlook
31.10Eastern North Pacific Tropical Weather Outlook
31.10Atlantic Tropical Weather Outlook
31.10Eastern North Pacific Tropical Weather Outlook
31.10Eastern North Pacific Tropical Weather Outlook
31.10Atlantic Tropical Weather Outlook
Transportation and Logistics »
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11How Japan's youngest CEO transformed Hello Kitty
31.10Unicharm to Expand in Africa
31.10Essity Named Diversity Leader by Financial Times
31.10Maxcess to Make FIFE Guiding Products in Mumbai
31.10Renee Starr Joins Hospeco
31.10RRD expands emissions reduction efforts
More »